T-cells in Pfizer Covid jab recipients stay robust against severe illness
5 posters
Page 1 of 1
T-cells in Pfizer Covid jab recipients stay robust against severe illness
T-cells in Pfizer Covid jab recipients stay robust against severe illness
https://www.theguardian.com/world/2021/dec/17/t-cells-pfizer-covid-jab-robust-against-severe-illness-south-africa-research
SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron
https://www.mdpi.com/1999-4915/14/1/79/htm
https://www.theguardian.com/world/2021/dec/17/t-cells-pfizer-covid-jab-robust-against-severe-illness-south-africa-research
SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron
https://www.mdpi.com/1999-4915/14/1/79/htm
planetcare- Contributor Plus
- Number of posts : 755
Registration date : 2019-09-27
Re: T-cells in Pfizer Covid jab recipients stay robust against severe illness
a trial treatment that masquerades as a vaccine that has to be retaken every 3 months is really not a vaccine at all and should be renamed to something more like a treatment, which is at least closer to the truth
GR84UMR- Contributor
- Number of posts : 20
Registration date : 2022-04-25
Firefly likes this post
Re: T-cells in Pfizer Covid jab recipients stay robust against severe illness
wrong! Its not a trial treatment and fulfills all the scientific and immunological criteria to be called a vaccine! as the links to some published studies i have previously posted clearly demonstrate!GR84UMR wrote:a trial treatment that masquerades as a vaccine that has to be retaken every 3 months is really not a vaccine at all and should be renamed to something more like a treatment, which is at least closer to the truth
planetcare- Contributor Plus
- Number of posts : 755
Registration date : 2019-09-27
Re: T-cells in Pfizer Covid jab recipients stay robust against severe illness
planetcare wrote:wrong! Its not a trial treatment and fulfills all the scientific and immunological criteria to be called a vaccine! as the links to some published studies i have previously posted clearly demonstrate!GR84UMR wrote:a trial treatment that masquerades as a vaccine that has to be retaken every 3 months is really not a vaccine at all and should be renamed to something more like a treatment, which is at least closer to the truth
it most definitely is still in the trial stages and therefore is should be classified as a trial treatment and nothing more, as to whether it works as claimed or not is not the point
GR84UMR- Contributor
- Number of posts : 20
Registration date : 2022-04-25
Re: T-cells in Pfizer Covid jab recipients stay robust against severe illness
GR84UMR wrote:
it most definitely is still in the trial stages and therefore is should be classified as a trial treatment and nothing more, as to whether it works as claimed or not is not the point
Again you are wrong! More than 12 billion shots have now been administered globally which means its well beyond the trail stage!!!!
Also all the covid vaccines went through rigorous, randomized double blind testing and clinical trials from phase 1 to phase 3 and published the results in the best peer reviewed medical journals, just the same as any other approved vaccine!
planetcare- Contributor Plus
- Number of posts : 755
Registration date : 2019-09-27
Re: T-cells in Pfizer Covid jab recipients stay robust against severe illness
[quote="planetcare"]
you can say it has been as many doses as you like have been administered, but it is still in its trail stage until some time in 2023 before it gets a final approval or rejection, that's how it is, no matter what you say won't change that
GR84UMR wrote:
Again you are wrong! More than 12 billion shots have now been administered globally which means its well beyond the trail stage!!!!
you can say it has been as many doses as you like have been administered, but it is still in its trail stage until some time in 2023 before it gets a final approval or rejection, that's how it is, no matter what you say won't change that
GR84UMR- Contributor
- Number of posts : 20
Registration date : 2022-04-25
Re: T-cells in Pfizer Covid jab recipients stay robust against severe illness
so planetcare, just to make it very clear the covid vaccine is still in "emergency trial use stage" and may never reach full approval
the Pfizer annual report to share holders is telling them this, you don't have to believe me but you can read it for yourself and Pfizer seem very concerned that their share price will fall big time if the full approval is denied
this is a small part of the Pfizer annual report to shareholders
this is what is highlighted just incase you cant read it
“We many not be able to demonstrate sufficient efficacy or safety of our COVID–19 vaccine and/or variant-specific formulations to obtain permanent regulatory approval in the United States the United Kingdom the European Union, or other countries where it has been authorized for emergency use or granted conditional marketing approval”
you can hear more of these reporters discussing the report if you want on youtube
https://youtudotbe/U3bXXqUO6eQ
replace the word dot with . if you want the link to work
the Pfizer annual report to share holders is telling them this, you don't have to believe me but you can read it for yourself and Pfizer seem very concerned that their share price will fall big time if the full approval is denied
this is a small part of the Pfizer annual report to shareholders
this is what is highlighted just incase you cant read it
“We many not be able to demonstrate sufficient efficacy or safety of our COVID–19 vaccine and/or variant-specific formulations to obtain permanent regulatory approval in the United States the United Kingdom the European Union, or other countries where it has been authorized for emergency use or granted conditional marketing approval”
you can hear more of these reporters discussing the report if you want on youtube
https://youtudotbe/U3bXXqUO6eQ
replace the word dot with . if you want the link to work
GR84UMR- Contributor
- Number of posts : 20
Registration date : 2022-04-25
Firefly likes this post
Re: T-cells in Pfizer Covid jab recipients stay robust against severe illness
US Securities And Exchange Commission (SEC) filings dated, 30th March 2022, from page 6 under the section titled 'Risk Factors'.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1776985/000177698522000019/bntx-20211231.htm
As GR84UMR also noted in his post above ....
•Our revenue depends heavily on sales of our COVID-19 vaccine, and our future revenues from our COVID-19 vaccine are uncertain.
•We may not be able to demonstrate sufficient efficacy or safety of our COVID-19 vaccine and/or variant-specific formulations to obtain permanent regulatory approval in the United States, the United Kingdom, the European Union, or other countries where it has been authorized for emergency use or granted conditional marketing approval.
•Significant adverse events may occur during our clinical trials or even after receiving regulatory approval, which could delay or terminate clinical trials, delay or prevent regulatory approval or market acceptance of any of our product candidates.
Another large tranch of documents is going to be released soon, 80,000 pages I believe.
More info and data from the inner workings of the company to consider.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1776985/000177698522000019/bntx-20211231.htm
As GR84UMR also noted in his post above ....
•Our revenue depends heavily on sales of our COVID-19 vaccine, and our future revenues from our COVID-19 vaccine are uncertain.
•We may not be able to demonstrate sufficient efficacy or safety of our COVID-19 vaccine and/or variant-specific formulations to obtain permanent regulatory approval in the United States, the United Kingdom, the European Union, or other countries where it has been authorized for emergency use or granted conditional marketing approval.
•Significant adverse events may occur during our clinical trials or even after receiving regulatory approval, which could delay or terminate clinical trials, delay or prevent regulatory approval or market acceptance of any of our product candidates.
Another large tranch of documents is going to be released soon, 80,000 pages I believe.
More info and data from the inner workings of the company to consider.
Firefly- Seasoned Contributor
- Number of posts : 149
Registration date : 2011-06-01
GR84UMR likes this post
Re: T-cells in Pfizer Covid jab recipients stay robust against severe illness
what a laugh.GR84UMR wrote:so planetcare, just to make it very clear the covid vaccine is still in "emergency trial use stage" and may never reach full approval
the Pfizer annual report to share holders is telling them this, you don't have to believe me but you can read it for yourself and Pfizer seem very concerned that their share price will fall big time if the full approval is denied
this is a small part of the Pfizer annual report to shareholders
this is what is highlighted just incase you cant read it
“We many not be able to demonstrate sufficient efficacy or safety of our COVID–19 vaccine and/or variant-specific formulations to obtain permanent regulatory approval in the United States the United Kingdom the European Union, or other countries where it has been authorized for emergency use or granted conditional marketing approval”
you can hear more of these reporters discussing the report if you want on youtube
https://youtudotbe/U3bXXqUO6eQ
replace the word dot with . if you want the link to work
You do realise you're quoting a subsection of the report that is outlining "possible" business risks that may affect shareholder returns &/or share prices don't you
That's got nothing whatsoever to do with the vaccine safety or efficacy & is just a business risks profile for shareholders.
In August 2021 the FDA in the USA granted full approved the Pfizer vaccine for those 16 years or older. Other age brackets & countries will follow.
Get off the tin foil hat sites bloke
mbasko- Good Contributor
- Number of posts : 104
Registration date : 2017-05-14
Re: T-cells in Pfizer Covid jab recipients stay robust against severe illness
Enough of the fors & against gents. The circumstances of covid-19 are what they are & there's nothing any one of us can do in order to change what is, or what is not happening. This is just argument for the sake of argument, in order to sh*t stir the pot.
Freedom of speech, doesn't mean it gives the individual the right to spread BS, or one conspiracy theory after the other on here.
Give this subject a rest, before I decide to put things to rest.
Management.
Freedom of speech, doesn't mean it gives the individual the right to spread BS, or one conspiracy theory after the other on here.
Give this subject a rest, before I decide to put things to rest.
Management.
Similar topics
» "Flurona" co-infection increases the risk of severe illness and death
» Expert reaction to two papers looking at T cells (after COVID-19 vaccination or infection) and Omicron
» Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19
» Claim : MIT Study Did NOT Prove Pfizer Vaccine Raised Heart Problems!
» Best SDC 2300 C cells
» Expert reaction to two papers looking at T cells (after COVID-19 vaccination or infection) and Omicron
» Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19
» Claim : MIT Study Did NOT Prove Pfizer Vaccine Raised Heart Problems!
» Best SDC 2300 C cells
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum